Lipegfilgrastim
- Generic Name
- Lipegfilgrastim
- Brand Names
- Lonquex
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 1117844-87-7
- Unique Ingredient Identifier
- 4AWF0N6QV3
- Background
Lipegfilgrastim, previously known as XM22, is a pegylated, recombinant granulocyte colony-stimulating factor (G-CSF) that was synthetized using a highly site-specific glycoPEGylation technology . It is used as an alternate to Pegfilgrastim for prophylactic use in cancer patients receiving chemotherapy and at risk for developing chemotherapy-induced neutropen...
- Indication
Indicated for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in adult patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes) .
- Associated Conditions
- Febrile Neutropenia, Neutropenia
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath